All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your GvHD Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
2022-12-07T15:51:12.000Z

Comparison of endoscopic and histological signs of aGvHD in the upper gastrointestinal tract

Dec 7, 2022
Share:
Learning objective: After reading this article, learners will be able to cite a new clinical development in acute GI GvHD.

Bookmark this article

Allogenic hematopoietic stem cell transplantation (allo-HSCT) represents a potentially curative therapy for patients with high-risk hematological malignancies. Complications can occur when donor immune cells attack healthy recipient cells resulting in graft-versus-host disease (GvHD). Acute GvHD (aGvHD) commonly affects the gastrointestinal tract (GIT), with severe cases conferring an adverse prognosis.1

The symptoms of GIT aGvHD include nausea, vomiting, anorexia, and dyspepsia, with histological analysis of biopsies playing a vital role in diagnosis.2 The correlation between endoscopic and histological findings has not been well established for the upper GIT.2

Below, we summarize a recent article published by Kreft, et al.2 in Leukemia & Lymphoma evaluating the correlation between the histological diagnosis of aGvHD and endoscopic findings of the upper GIT.

Study design and patient characteristics

This retrospective analysis included 97 patients who received allo-HSCT between 2006 and 2019. The median age was 54 years and the median days after allo-HSCT was 113 days (Table 1). Biopsy specimens were assessed for histological signs of aGvHD using the Lerner scheme (Grade 0: normal epithelia; Grade 1: single-cell apoptosis; Grade 2: crypt destruction; Grade 3: focal epithelial loss; Grade 4: diffuse epithelial loss, denudation)3,4,5 and the adaptation for esophagus GvHD (Grade 0: normal epithelia; Grade 1: cytoplasmic vacuolization; Grade 2: single-cell apoptosis; Grade 3: separation of the stroma-epithelial junction; Grade 4: denudation).6

Table 1. Patient characteristics*

Characteristics, n (unless otherwise stated)

N = 97

Male

54

Median age (range), years

51 (19–72)

Median days after allo-HSCT (range), days

113 (16–4,000)

Disease

 

              AML

47

              MDS

7

              MDS/MPN

2

              MPN

9

              ALL

7

              Lymphoma

211

              Aplastic anemia

3

              BPDCN

1

Donor type

 

              Sibling HLA-identical

18

              Unrelated HLA-identical

50

              Unrelated HLA-mismatch

23

              Unknown

6

ALL, acute lymphoblastic leukemia; allo-HSCT, allogenic hematopoietic stem cell transplantation; AML, acute myeloid leukemia; BPDCN, blastic plasmacytoid dendritic cell neoplasm; HLA, human leucocyte antigen; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm.
*Adapted from Kreft, et al.2

Results

Biopsy sites

Overall, 59 patients had biopsies from all four sites of the upper GIT (duodenum, antrum, corpus, and esophagus).

Three sites were biopsied in 20 patients:

  • Antrum, corpus, and esophagus: 11
  • Duodenum, antrum, and corpus: 8
  • Duodenum, antrum, and esophagus: 1

Two sites were biopsied in 11 patients:

  • Antrum and corpus: 6
  • Duodenum and corpus: 2
  • Duodenum and antrum: 1
  • Corpus and esophagus: 1
  • Duodenum and esophagus: 1

Only one site was biopsied in 7 patients:

  • Antrum: 5
  • Corpus: 1
  • Esophagus: 1

Histological signs of GvHD

  • Histological signs of GvHD were present in 48 patients
  • The duodenum was the site with the most histological signs of aGvHD, with significantly more than in the corpus (p = 0.004) and antrum (p = 0.01)
  • The esophagus had the second highest, with significantly more than the corpus (p = 0.001) and antrum (p = 0.005)
  • There were no significant differences in histological signs between the corpus and antrum
  • The correlation of histological aGvHD grades within different biopsy sites was poor (Fleiss’ kappa = 0.33)
  • In terms of endoscopic findings, ulcers, erosion, atrophy, and white plaques were significantly associated with histological signs of aGvHD (Table 2)
  • In some cases where endoscopic findings were present but there were no histological signs of aGvHD, histological signs of aGvHD were found in biopsies from other sites
  • Signs of aGvHD outside the upper GIT were present in the skin (n = 53), lower GIT (n = 20), and liver (n = 11), of which 31, 20, and 4 patients had histological signs of GvHD in upper GIT biopsies  

Table 2. Statistically significant association between histological and endoscopic findings*

Site

Endoscopic
finding, Lerner grade

Histology GvHD

0
(no GvHD)

1

2

3

4

Esophagus
(n = 74)

All

38

14

14

8

2

White
plaque

2

1

3

Corpus
(n = 88)

All

60

19

8

0

1

Ulcer

1

2

Antrum
(n = 91)

All

57

24

7

1

2

Ulcer

1

1

Duodenum
(n = 72)

All

30

27

6

3

6

Atrophy

2

2

Erosion

9

2

1

1

GvHD, graft-versus-host disease.
*Adapted from Kreft, et al.2
Indicates statistically significant association between endoscopic finding and histological results (p ≤ 0.05).

Survival outcomes

In total, 57 patients died (Figure 1). The mean observation period was 694 days (range, 31–7,576 days).

Histological signs of aGvHD in all four sites were significantly associated with overall mortality:

  • Esophagus hazard ratio (HR): 2.0, 1.1–3.6; p = 0.02
  • Corpus HR: 1.8, 1.0–3.1; p = 0.05
  • Antrum HR: 2.0, 1.1–3.4, p = 0.01
  • Duodenum HR: 2.2, 1.1–4.1; p = 0.02

The maximal Lerner grade of 2 (HR, 2.7, 1.0–7.33; p = 0.03) and having more than two sites with histological signs of aGvHD (HR, 3.1, 1.1–8.9; p = 0.055) had a significant effect on overall survival. Non-relapse mortality was significantly associated with histological signs of GvHD in the antrum (HR, 1.8, 1.1–3.2; p = 0.03) but not other locations, the number of sites involved, or the maximum Lerner grade.

Figure 1. Causes of death among patients* 

GvHD, graft-versus-host disease.
*Data from Kreft, et al.2

Conclusion

In this retrospective analysis across four sites, the duodenum and esophagus had the highest proportion of histological signs of aGvHD in the upper GIT, suggesting biopsies should focus on these two sites. Although the endoscopic findings of white plaques, ulcers, atrophy, and erosion were significantly associated with histological signs of aGvHD, there was also no correlation between endoscopic findings and histological signs of aGvHD for several patients. 

  1. Naymagon S, Naymagon L, Wong SY, et al. Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nat Rev Gastroenterol Hepatol. 2017;14(12):711-726. DOI: 1038/nrgastro.2017.126
  2. Kreft A, Schulze L, Ries I, et al. Histological diagnosis of acute graft-versus-host disease in different sites of the upper gastrointestinal tract with correlation to endoscopic findings. Leuk Lymphoma. 2022. Online ahead of print. DOI: 1080/10428194.2022.2142056
  3. Heymar B. Clinical and diagnostic pathology of graft-versus-host disease. 1st ed. Springer; 2002.
  4. Lerner KG, Kao GF, Storb R, et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc. 1974;6(4):367-371.
  5. Kreft A, Mottok A, Mestri I, et al. Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility. Virchows Arch. 2015;467(3):255-263 DOI: 1007/s00428-015-1803-y
  6. Kreft A, Neumann H, Bach DSV, et al. Histologic diagnosis and grading of esophageal acute graft-versus-host disease. Virchows Arch. 2019;474(3):325-332. DOI: 1007/s00428-018-2507-x

Newsletter

Subscribe to get the best content related to GvHD delivered to your inbox